Precision BioSciences, Inc.DTILNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank44
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-66.19M
↓ 39% vs avg
Percentile
P44
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-47.47M
Historical baseline
PeriodValueYoY Change
TTM$-66.19M-12.8%
2024$-58.70M+32.1%
2023$-86.39M-76.1%
2022$-49.07M-194.6%
2021$-16.66M+82.0%
2020$-92.42M+6.0%
2019$-98.30M-45.8%
2018$-67.40M-126.7%
2017$-29.73M-133.0%
2016$90.20M-